| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | 18 Sep 2024 | Direct |
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 45,000 | 02 Dec 2025 | Direct | ||
| G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | 18 Sep 2024 | Direct | ||
| GW PHARMACEUTICALS PLC | Director | Ordinary Shares | 0 | 05 May 2021 | Direct | ||
| GW PHARMACEUTICALS PLC | Director | Share Options | 0 | 05 May 2021 | Direct | ||
| Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | 24 Jan 2024 | Direct |